Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 12, 2009

BG Medicine, NHLBI, and Boston University Partner for Cardiovascular Biomarker Discovery

  • BG Medicine, the National Heart, Lung, and Blood Institute (NHLBI), and Boston University (BU) will jointly undertake biomarker discovery studies for heart disease and early detection of metabolic syndrome.

    Under this CRADA, BG Medicine's technology will be used to analyze biosamples obtained during years of collection by Framingham Heart Study researchers. The Framingham Heart Study is funded by NHLBI and conducted in collaboration with BU's School of Medicine and School of Public Health.

    Only information from participants who have consented to sharing their specimens and data with commercial researchers will be used, and all shared information will be de-identified to protect participants' privacy.

Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.